Dov V. Shimon

Part of Shimoco LLC, Sagax Medical Technologies, Inc. develops proprietary solutions to reduce the risk of strokes and other serious complications resulting from cardiac procedures, as well as naturally occurring Cardioembolic Strokes. The company is based in Herzliya, Israel. The Israeli company was founded by Dov V. Shimon, who has been the CEO since incorporation. Sagax Medical Technologies was acquired by Shimoco LLC from MIV Therapeutics, Inc. on December 28, 2007.

Keystone Heart Ltd. engages in the development and manufacture of cerebral embolic protection devices that aim to reduce the risk of stroke, neurocognitive decline, and dementia caused by brain damage associated with cardiovascular procedures. The company was founded by Dov V. Shimon in 2004 and is headquartered in Caesarea, Israel.

MIV Therapeutics, Inc. is an advanced stage, research and development company. It is engaged in developing a next-generation line of advanced biocompatible coatings for passive and drug-eluting applications on cardiovascular stents and for a broad range of other implantable medical devices. The company was founded by Alan P. Lindsay on January 20, 1999 and is headquartered in Vancouver, Canada.